50 Results for "

aPD-L1

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "aPD-L1" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-P73361
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD274; B7 Homolog 1; Prev. PDCD1LG1; B7-H; PD-L1; PDCD1 Ligand 1; B7H1; PDCD1L1; PDL1; HPD-L1; Programmed Cell Death 1 Ligand 1; Programmed Death Ligand 1; CD274 Antigen; ADMIO5; CD274 Molecule; B7-H1
Species:  
Human
Source:  
HEK293
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P70632
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD274; B7 Homolog 1; Prev. PDCD1LG1; B7-H; PD-L1; PDCD1 Ligand 1; B7H1; PDCD1L1; PDL1; HPD-L1; Programmed Cell Death 1 Ligand 1; Programmed Death Ligand 1; CD274 Antigen; ADMIO5; CD274 Molecule; B7-H1
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P990173

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Anti-Mouse/Rat/Human PD-L1 Antibody (368A.4H1) is a mouse-derived PD-L1 IgG1 κ type antibody inhibitor. Anti-Mouse/Rat/Human PD-L1 Antibody (368A.4H1) increases IFN-γ levels in organoid-primed T cells. Anti-Mouse/Rat/Human PD-L1 Antibody (368A.4H1) can be used for the researches of cancer, such as oral squamous cell carcinoma and mammary cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-163757
CAS No.: 3052114-77-6
Target:  

PROTACs PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PROTAC PD-L1 degrader-1 is a CRBN-based PD-L1-PROTAC degrader with a notable PD-L1 protein degradation capability. PROTAC PD-L1 degrader-1 shows potent PD-L1 degradation in 4T1 cells with a DC50 of 0.609 μM. PROTAC PD-L1 degrader-1 can be used for the study of breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P7397
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD274; B7 Homolog 1; Prev. PDCD1LG1; B7-H; PD-L1; PDCD1 Ligand 1; B7H1; PDCD1L1; PDL1; HPD-L1; Programmed Cell Death 1 Ligand 1; Programmed Death Ligand 1; CD274 Antigen; ADMIO5; CD274 Molecule; B7-H1
Species:  
Human
Source:  
CHO
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P84982
Synonyms: Programmed cell death 1 ligand 1; PD-L1; PDCD1 ligand 1; Programmed death ligand 1; B7 homolog 1; B7-H1; CD antigen CD274; CD274 nanobody; PD-L1 nanobody;

Host:  

Rabbit

Application:  

WB, IHC-P, IP, mIHC

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P10950A
Target:  

PD-1/PD-L1 Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

PD-L1 inhibitory peptide TFA is an inhibitor targeting the PD-1/PD-L1 interaction. PD-L1 inhibitory peptide TFA inhibits the PD-1-mediated apoptosis signaling pathway, maintains the survival and activity of T cells, activates the anti-tumor effect of cytotoxic T lymphocytes, and significantly improves the survival rate of mice in fungal sepsis models. PD-L1 inhibitory peptide TFA can be used for research on sepsis, breast cancer and other related diseases, as well as immunotherapy .
loading...
    loading...
Cat. No.: HY-P10950
CAS No.: 1931111-41-9
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PD-L1 inhibitory peptide is an inhibitor peptide targeting programmed cell death ligand 1 (PD-L1). PD-L1 inhibitory peptide binds to PD-L1, relieving immunosuppression and restoring the antitumor activity of T cells. PD-L1 inhibitory peptide is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-P2478
CAS No.: 2815311-61-4
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

Human PD-L1 inhibitor V, a human PD-1 protein binding peptide with a Kd value of 3.32 μM. Human PD-L1 inhibitor V inhibit the interaction of hPD-1/hPD-L1 .
loading...
    loading...
Cat. No.: HY-P2477
CAS No.: 2135542-83-3
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

Human PD-L1 inhibitor IV, a polypeptide, is a competitive human PD-1 protein inhibitor with a Kd value of 1.38 μM. Human PD-L1 inhibitor IV inhibits the interaction of hPD-1/hPD-L1 .
loading...
    loading...
Cat. No.: HY-162972
CAS No.: 2995357-09-8
Target:  

PROTACs PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PROTAC PD-L1 degrader-2 is a PD-L1 PROTAC degrader with an IC50 of 197.4 nM and a Kd of 301 nM. PROTAC PD-L1 degrader-2 induces PD-L1 endocytosis, drives degradation via the proteasomal and lysosomal pathways, and inhibits the PD-1/PD-L1 interaction. As an immune activator, PROTAC PD-L1 degrader-2 increases the levels of CD4 +, CD8 +, granzyme B and perforin. PROTAC PD-L1 degrader-2 can be used in studies related to colon cancer immunology .
loading...
    loading...
Cat. No.: HY-P2470
CAS No.: 2135542-85-5
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Human PD-L1 inhibitor II is a potent PD-L1 inhibitor with anti-cancer activity .
loading...
    loading...
Cat. No.: HY-P2474
CAS No.: 2135542-86-6
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Human PD-L1 inhibitor I is a hPD-1 peptide ligand, with a KD of 3.39 μM. Human PD-L1 inhibitor I may disturb the binding of hPD-L1 to hPD-1 .
loading...
    loading...
Cat. No.: HY-P2478A
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

Human PD-L1 inhibitor V TFA, a human PD-1 protein binding peptide with a Kd value of 3.32 μM. Human PD-L1 inhibitor V TFA inhibit the interaction of hPD-1/hPD-L1 .
loading...
    loading...
Cat. No.: HY-P2564
CAS No.: 2135542-84-4
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

Human PD-L1 inhibitor III is a human PD-L1 inhibitor.
loading...
    loading...
Cat. No.: HY-162973
Research Areas:  

Cancer

PD-L1 ligand 1 is a PROTAC target protein ligand. PD-L1 ligand 1 can be used as a PD-L1 degrader .
loading...
    loading...
Cat. No.: HY-P5276
CAS No.: 1831010-13-9
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Human membrane-bound PD-L1 polypeptide can be used as an antigen to induce PD-L1 antibody production .
loading...
    loading...
Cat. No.: HY-190133
CAS No.: 3123326-31-5
Research Areas:  

Neurological Disease

PD-L1 antagonist-1 is a PD-L1 antagonist and a Molecular Glue. PD-L1 antagonist-1 induces PD-L1 dimerization/oligomerization and blocks the PD-1/PD-L1 interaction with an IC50 of 254 nM. PD-L1 antagonist-1 can be used in research related to neurological diseases .
loading...
    loading...
Cat. No.: HY-190134
CAS No.: 3123326-21-3
Research Areas:  

Cancer

PD-L1 antagonist-2 is a PD-L1 antagonist with an IC50 of 408 nM. PD-L1 antagonist-2 is also a molecular glue. PD-L1 antagonist-2 induces PD-L1 dimerization/oligomerization and blocks the PD-1/PD-L1 interaction. PD-L1 antagonist-2 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-P7398
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD274; B7 Homolog 1; Prev. PDCD1LG1; B7-H; PD-L1; PDCD1 Ligand 1; B7H1; PDCD1L1; PDL1; HPD-L1; Programmed Cell Death 1 Ligand 1; Programmed Death Ligand 1; CD274 Antigen; ADMIO5; CD274 Molecule; B7-H1
Species:  
Human
Source:  
HEK293
loading...
    loading...